University of Rome
Welcome,         Profile    Billing    Logout  
 2 Trials 
3 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Fabbrini, Giovanni
ORION, NCT06122662: AMX0035 and Progressive Supranuclear Palsy

Active, not recruiting
2/3
110
Europe, US
AMX0035, Placebo
Amylyx Pharmaceuticals Inc.
Progressive Supranuclear Palsy, PSP, Neurodegenerative Diseases, Atypical Parkinsonism
04/26
11/29
Royal, NCT04560101: Motor and Non-motor Symptoms in Cervical Dystonia

Recruiting
N/A
43
Europe
botulinum toxin A
University of Roma La Sapienza, Ipsen
Dystonia, Focal
02/21
06/21
Barbetti, Fabrizio
iDEND, NCT05751525: Impact of Sulphonylureas on Neurodevelopmental Outcomes in KCNJ11-related Intermediate Developmental Delay, Epilepsy and Neonatal Diabetes () Syndrome

Recruiting
N/A
21
Europe, US
Sulfonylurea
Royal Devon and Exeter NHS Foundation Trust, University of Chicago, University of Bergen, University of Rome Tor Vergata
Neurodevelopmental Disorders, Intellectual Disability, Development Delay, ADHD, Autism Spectrum Disorder, Epilepsy
08/25
12/25

Download Options